title: Response to "Insulin-like growth factor 1 receptor signaling via Akt: a general therapeutic target in neurocutaneous melanocytosis?".
authors.affiliation: Division of Pediatric Oncology, Alberta Children's Hospital and POETIC Laboratory for Preclinical and Drug Discovery Studies, University of Calgary, Calgary, Alberta, Canada.
authors.forename: Yibing
authors.initials: Y
authors.lastname: Ruan
authors.affiliation: Division of Pediatric Oncology, Alberta Children's Hospital and POETIC Laboratory for Preclinical and Drug Discovery Studies, University of Calgary, Calgary, Alberta, Canada.
authors.forename: Aru
authors.initials: A
authors.lastname: Narendran
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008548:Melanosis / Q000188:drug therapy* / Q000235:genetics*; D020752:Neurocutaneous Syndromes / Q000188:drug therapy* / Q000235:genetics*; D023041:Xenograft Model Antitumor Assays / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents